|
SCAMP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.64559999983017E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.68200000488983E-08 |
| Normal-vs-Stage2 |
6.680200E-02 |
| Normal-vs-Stage3 |
6.103600E-02 |
| Normal-vs-Stage4 |
6.709700E-02 |
| Stage1-vs-Stage2 |
2.268400E-01 |
| Stage1-vs-Stage3 |
2.463600E-01 |
| Stage1-vs-Stage4 |
6.386200E-01 |
| Stage2-vs-Stage3 |
9.110800E-01 |
| Stage2-vs-Stage4 |
2.524000E-01 |
| Stage3-vs-Stage4 |
3.130400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.53970000030357E-07 |
| Normal-vs-AfricanAmerican |
5.922300E-03 |
| Normal-vs-Asian |
1.414000E-01 |
| Caucasian-vs-AfricanAmerican |
2.654000E-01 |
| Caucasian-vs-Asian |
6.565600E-01 |
| AfricanAmerican-vs-Asian |
4.243200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59280000003415E-06 |
| Normal-vs-Female |
1.636640E-04 |
| Male-vs-Female |
9.633200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.019800E-04 |
| Normal-vs-Extreme_Weight |
6.893500004157E-08 |
| Normal-vs-Obese |
1.719860E-02 |
| Normal-vs-Extreme_Obese |
1.700410E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.051800E-01 |
| Normal_Weight-vs-Obese |
2.527400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.140400E-01 |
| Extreme_Weight-vs-Obese |
7.317500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.012200E-01 |
| Obese-vs-Extreme_Obese |
7.604000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.712590E-01 |
| Normal-vs-Age(41-60Yrs) |
1.060250E-03 |
| Normal-vs-Age(61-80Yrs) |
1.63039999945269E-07 |
| Normal-vs-Age(81-100Yrs) |
2.755900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.129600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.014000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.279000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.288400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.65219999999478E-05 |
| Normal-VS-Type2 PRCC |
1.78785999999098E-05 |
| Normal-VS-KIRP CIMP |
4.52360000013918E-07 |
| Normal-VS-Unclassified PRCC |
4.782400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.197600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.060400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.297800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.593200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.507600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.621300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.49890000000508E-05 |
| Normal-vs-N1 |
4.184300E-02 |
| Normal-vs-N2 |
7.784300E-02 |
| N0-vs-N1 |
6.142000E-01 |
| N0-vs-N2 |
1.195830E-01 |
| N1-vs-N2 |
1.822980E-01 |
|
|
